Skip to main content
. 2011 Aug 15;53(4):334–340. doi: 10.1093/cid/cir402

Figure 1.

Figure 1.

Kaplan–Meier estimates of the cumulative risk of failure according to the treatment group assessed at 24 months follow-up. Patients in the rifampin-fluoroquinolone treatment group had a lower risk of experiencing treatment failure than did patients treated with other antibiotic regimens (P = .003). Dotted line, rifampin-fluoroquinolone treatment group (n = 39); solid line, other regimens group (n = 59).